References
1. Aquaro GD, Barison A, Cagnolo A, Todiere G, Lombardi M, Emdin M. Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis. Int J Cardiovasc Imaging. 2015 Jun;31(5):1021–31.
2. Garcia MJ. Constrictive Pericarditis Versus Restrictive Cardiomyopathy? J Am Coll Cardiol. 2016 May 3;67(17):2061–76.
3. Pelliccia A, Solberg EE, Papadakis M, Adami PE, Biffi A, Caselli S, et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). European Heart Journal. 2019 Jan 1;40(1):19–33.
4. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NAM, et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. Lippincott Williams & Wilkins Hagerstown, MD; 2015 Dec 1;132(22):e273–80.
Notes to editor
Author information:
Nikhil Ahluwalia, Cardiology Registrar, Bart’s Heart Centre, London, UK, Sports Cardiology MSc student, Cardiology Clinical Academic Group, St George’s University of London.
James C. Moon, Consultant Cardiologist, Bart’s Health Centre, London, UK. Professor of Cardiology, NIHR University College London Hospitals Biomedical Research Centre, London, UK.




